Description
GLUCOWELL-MET 50/850 mg Tablets (28’s)
GLUCOWELL-MET 50/850 mg Tablets are a fixed-dose combination of Sitagliptin (50 mg) and Metformin Hydrochloride (850 mg), formulated to provide effective blood glucose control in adults with type 2 diabetes mellitus. This dual therapy is suitable for patients who are inadequately controlled with metformin alone or who are already being treated with the individual components.
Sitagliptin, a DPP-4 inhibitor, works by enhancing the body’s natural incretin system to increase insulin release and decrease glucagon levels in a glucose-dependent manner. Metformin complements this action by decreasing hepatic glucose production and improving insulin sensitivity, resulting in comprehensive control of both fasting and postprandial blood sugar levels.
The 28-tablet pack offers a convenient four-week supply for once- or twice-daily use, depending on the prescribed regimen. It is typically used alongside dietary adjustments and physical activity to support long-term diabetes management.
Key Features:
-
Contains Sitagliptin 50 mg and Metformin 850 mg per tablet
-
Dual mechanism: improves insulin secretion and reduces liver glucose production
-
Suitable for patients needing combination therapy
-
Weight-neutral with low risk of hypoglycemia
-
Supports improved glycemic control and treatment adherence
-
28-tablet pack for easy monthly supply
Use only under the supervision of a healthcare provider as part of a comprehensive diabetes treatment plan.
Reviews
There are no reviews yet.